Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Centessa Pharmaceuticals LimitedCNTA-12.90303.489.67-7.97-42.52%-37.92%55.75$16.74$45.5122,365$17.89

Detail of Centessa Pharmaceuticals Limited

 
CEO
Dr. Saurabh Saha M.D., Ph.D.
Employees
76
Industry
Biotechnology
Sector
Healthcare
Market cap
$2B

Company details

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Revenue
Revenue (Rev)
$6.85M
Centessa Pharmaceuticals Limited
CNTA • XNGS • US
$17.89
+8.63 (93.20%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.39
Margin profit
0.00%
52 week low
$8.04
52 week high
$18.67
50-day simple moving average
$16.86
200-day simple moving average
$16.74
Percent held by insiders
1.24%
Percent held by institutions
92.55%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
CNTA +86.35%
eps change
CNTA 0.00%